Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Zaid Admani

👤 Speaker
1016 total appearances

Appearances Over Time

Podcast Appearances

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

So that could get really messy.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Don't be surprised if this decision leads to more market volatility.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

So yeah, it's a very interesting moment in the markets right now.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

We'll see how things play out over the next few weeks as investors wait for the Supreme Court ruling and as more companies start reporting earnings.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Now, I'm really looking forward to the big tech earnings because the tech sector has been a weak spot so far this year, and we'll see if that bounces back if these big tech giants post strong earnings.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Oh, and don't forget, we also got the beef between President Trump and Fed Chair Jerome Powell.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Now, speaking of the Fed, our deep dive for tomorrow is going to be about the history of the Federal Reserve.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

We're going to talk about why it was formed, some of the failures the Fed has had in the past, and why an independent Fed is so important.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

So if you want to learn more about the Federal Reserve, keep an eye on your podcast feed for that.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Also, I have to mention, this is kind of crazy, but I was actually quoted in an article in the Wall Street Journal this week about Fed Chair Jerome Powell.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

The reporter who wrote the article, Hannah Aaron Lang, she did a great job on the piece.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

She asked me why I thought that Powell gets memes so much on the internet.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

And I said, it's because he has aura.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Now, I said a bunch of other stuff, too, but they ran with the aura quote, which I think is just great.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

We even got a mention on The Wall Street Journal's Instagram page as well.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

So, yeah, that was a pretty surreal moment getting quoted in The Wall Street Journal.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

We'll put a link to the article in the description if you guys want to check that out.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Let's run through some headlines, starting with Eli Lilly and Novo Nordisk.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

Eli Lilly and Novo Nordisk are being sued over their GLP-1 duopoly.

The Rundown
Weight Loss Drugmakers Hit with Antitrust Lawsuit, Trump’s Plan Brings Down Energy Stocks

This lawsuit was filed by a compounding pharmacy called Strive Specialties, which alleges the two pharma giants are illegally blocking consumers from getting low-cost versions of their weight loss drugs.